Research & Development

Obesity

PYN22 for obesity

The worldwide obesity market has been predicted to reach US$2.54 billion by 2012. Phynova has recently begun development of a highly purified Chinese plant extract that has been shown to effectively lower expression of genes associated with obesity and fatty liver disease. In combination with PYN17, this product could benefit patients with inflamed livers associated with fatty diets or metabolic disease (e.g. diabetes).